Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:e119
doi: 10.1161/CIRCULATIONAHA.107.705160
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Augoustides, J. G.T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Augoustides, J. G.T.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Clinical Studies
Right arrow CV surgery: coronary artery disease
Right arrow Other Vascular biology
Right arrowRelated Article

(Circulation. 2007;116:e119.)
© 2007 American Heart Association, Inc.


Correspondence

Letter by Augoustides Regarding Article, "Risk Index for Perioperative Renal Dysfunction/Failure: Critical Dependence on Pulse Pressure Hypertension"

John G.T. Augoustides, MD

Assistant Professor, Department of Anesthesiology and Critical Care, Hospital of the University of Pennsylvania, Philadelphia

To the Editor:

I read with great interest the excellent article by Dr Aronson and colleagues detailing a risk index for perioperative renal dysfunction/failure after coronary revascularization requiring cardiopulmonary bypass.1 Their multivariate analysis has demonstrated the critical role of pulse pressure hypertension in perioperative renal injury. However, the data analysis, as presented, does not account for aprotinin exposure, a significant risk factor for perioperative renal injury as previously described by this research group.2

The consequent questions that arise from this observation include:

  1. What percentage of the study cohort (n=4801) was exposed to aprotinin?
  2. Was aprotinin exposure statistically equivalent in the derivation (n=2381) and validation (n=2420) cohorts?
  3. Is aprotinin exposure an independent predictor for renal injury in this study? If not, what are the possible explanations, given the prior published findings2?
  4. Is the described nephrotoxic interaction between angiotensin blockade and aprotinin an independent predictor of renal injury in this study?3 This consideration is relevant given that 43.9% of the total study cohort were taking preoperative ACE inhibitors.
  5. Is aprotinin exposure an independent predictor of renal injury with or without exposure to angiotensin blockade?3 In the report by Kincaid and colleagues,3 it was the combination of aprotinin and angiotensin blockade that was independently associated with renal failure after cardiac surgery with cardiopulmonary bypass.

I congratulate the authors on a most thought-provoking report. I look forward to understanding better the role of aprotinin exposure in their detailed study of renal injury after coronary revascularization requiring cardiopulmonary bypass.


*    Acknowledgments
 
Disclosures

Financial support for the author was provided by the Department of Anesthesiology and Critical Care, Hospital of the University of Pennsylvania. The author reports no conflicts.


*    References
up arrowTop
*References
 

  1. Aronson S, Fontes ML, Miao Y, Mangano DT; for the Investigators of the Multicenter Study of Perioperative Ischemia and the Ischemia Research and Education Foundation. Risk index for perioperative renal dysfunction/failure: critical dependence on pulse pressure hypertension. Circulation. 2007; 115: 733–742.[Abstract/Free Full Text]
  2. Mangano DT, Tudor JC, Dietzel C; for the Investigators of the Multicenter Study of Perioperative Ischemia and the Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006; 354: 353–365.[Abstract/Free Full Text]
  3. Kincaid EH, Ashburn DA, Hoyle JR, Reichert MG, Hammon JW, Kon ND. Does the combination of aprotinin and angiotensin enzyme inhibitor cause renal failure after cardiac surgery? Ann Thorac Surg. 2005; 80: 1388–1393.[Abstract/Free Full Text]

Related Article:

Issue Highlights
Circulation 2007 116: 457. [Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Augoustides, J. G.T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Augoustides, J. G.T.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Clinical Studies
Right arrow CV surgery: coronary artery disease
Right arrow Other Vascular biology
Right arrowRelated Article